Literature DB >> 16977375

Prevalence of anti-locus coeruleus immunoreactivity in CSF of patients with autonomic failure.

Richard Imrich1, David S Goldstein, David M Jacobowitz.   

Abstract

In this study we evaluated by indirect immunohistochemistry the prevalence of cerebrospinal fluid (CSF) antibodies reacting with structures of rat pons/medulla in patients with multiple system atrophy (MSA) (n = 29), Parkinson disease with neurogenic orthostatic hypotension (n = 13), or pure autonomic failure (n = 11) and in control subjects without autonomic failure (n = 33). About 10-20% of CSF samples had positive immunoreactivity to rat locus coeruleus (LC), regardless of clinical diagnosis. The results failed to confirm the previously reported high prevalence of immune binding to rat LC in CSF from patients with MSA.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16977375     DOI: 10.1007/s10286-006-0366-z

Source DB:  PubMed          Journal:  Clin Auton Res        ISSN: 0959-9851            Impact factor:   4.435


  11 in total

1.  Anti-Tr antibodies as markers of paraneoplastic cerebellar degeneration and Hodgkin's disease.

Authors:  F Bernal; S Shams'ili; I Rojas; R Sanchez-Valle; A Saiz; J Dalmau; J Honnorat; P Sillevis Smitt; F Graus
Journal:  Neurology       Date:  2003-01-28       Impact factor: 9.910

Review 2.  The distribution of Lewy bodies in pure autonomic failure: autopsy findings and review of the literature.

Authors:  K Hague; P Lento; S Morgello; S Caro; H Kaufmann
Journal:  Acta Neuropathol       Date:  1997-08       Impact factor: 17.088

3.  Plasma exchange for primary autoimmune autonomic failure.

Authors:  Christoph Schroeder; Steven Vernino; Andreas L Birkenfeld; Jens Tank; Karsten Heusser; Axel Lipp; Thomas Benter; Carsten Lindschau; Ralph Kettritz; Friedrich C Luft; Jens Jordan
Journal:  N Engl J Med       Date:  2005-10-13       Impact factor: 91.245

4.  Autoantibodies to ganglionic acetylcholine receptors in autoimmune autonomic neuropathies.

Authors:  S Vernino; P A Low; R D Fealey; J D Stewart; G Farrugia; V A Lennon
Journal:  N Engl J Med       Date:  2000-09-21       Impact factor: 91.245

5.  Autoimmune autonomic failure in a patient with myeloma-associated Shy-Drager syndrome.

Authors:  D S Goldstein; A McRae; C Holmes; M C Dalakas
Journal:  Clin Auton Res       Date:  1996-02       Impact factor: 4.435

6.  Myasthenia gravis with autoimmune autonomic neuropathy.

Authors:  S Vernino; W P Cheshire; V A Lennon
Journal:  Auton Neurosci       Date:  2001-05-14       Impact factor: 3.145

7.  Desensitization and sequestration of human m2 muscarinic acetylcholine receptors by autoantibodies from patients with Chagas' disease.

Authors:  C P Leiros; L Sterin-Borda; E S Borda; J C Goin; M M Hosey
Journal:  J Biol Chem       Date:  1997-05-16       Impact factor: 5.157

8.  The spectrum of antineuronal autoantibodies in a series of neurological patients.

Authors:  M Vianello; R Vitaliani; R Pezzani; P Nicolao; C Betterle; G Keir; E J Thompson; B Tavolato; F Scaravilli; B Giometto
Journal:  J Neurol Sci       Date:  2004-05-15       Impact factor: 3.181

9.  Antibody in the CSF of patients with multiple system atrophy reacts specifically with rat locus ceruleus.

Authors:  R J Polinsky; A McRae; S M Baser; A Dahlström
Journal:  J Neurol Sci       Date:  1991-11       Impact factor: 3.181

10.  Pandysautonomia associated with impaired ganglionic neurotransmission and circulating antibody to the neuronal nicotinic receptor.

Authors:  David S Goldstein; Courtney Holmes; Raghuveer Dendi; Sheng-Ting Li; Sandra Brentzel; Steven Vernino
Journal:  Clin Auton Res       Date:  2002-08       Impact factor: 4.435

View more
  1 in total

Review 1.  Diagnostic cerebrospinal fluid biomarkers for Parkinson's disease: a pathogenetically based approach.

Authors:  Karin D van Dijk; Charlotte E Teunissen; Benjamin Drukarch; Connie R Jimenez; Henk J Groenewegen; Henk W Berendse; Wilma D J van de Berg
Journal:  Neurobiol Dis       Date:  2010-05-06       Impact factor: 5.996

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.